Steven M. Friedman Insider Profile

4 Followers
Steven M. Friedman, EVP, Biology & Preclinical Dev at Incyte, holds 38.14K shares in Incyte (Ticker: INCY). Most recently, Steven M. Friedman Sold $22,000 shares of Incyte on Jan 08, 2010 for an estimated value of 239.80K.
Steven M. Friedman

Steven M. Friedman
Incyte (INCY)
EVP, Biology & Preclinical Dev

Not Ranked
Steven M. Friedman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
A breakdown of Steven M. Friedman's holdings

Insider Roles

Incyte
(INCY)
EVP, Biology & Preclinical Dev
Roles that Steven M. Friedman holds in companies

Most Profitable Insider Trade

Stock:
Incyte
(INCY)
Rating:Informative Sell
Date:Jan 08, 2010 - Jan 08, 2011
Return:-49.40%
The most profitable trade made by Steven M. Friedman

Steven M. Friedman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Incyte
Jan 08, 2010
EVP, Biology & Preclinical Dev
Informative Sell
$239.80K
$2.81M
Success Rate for INCY
0 out of 1 profitable transactions on INCY
0%
Average Return for INCY
Average return per transaction on INCY
-49.40%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 29, 2009
Uninformative Buy
-
$2.93
Jan 08, 2010
Informative Sell
$239.80K
-
$10.90
-49.40%
List of latest transactions for each holding click on a transaction to see Steven M. Friedman's performance on stock

Steven M. Friedman insider profile FAQ

What is the percentage of profitable transactions made by Steven M. Friedman?
The percentage of profitable transactions made by Steven M. Friedman is ―.
    What is the average return per transaction made by Steven M. Friedman?
    The average return per transaction made by Steven M. Friedman is ―.
      What stocks does Steven M. Friedman hold?
      Steven M. Friedman holds: INCY stocks.
        What was Steven M. Friedman’s latest transaction?
        Steven M. Friedman latest transaction was an Informative Sell of $239.80K.
          What was Steven M. Friedman's most profitable transaction?
          Steven M. Friedman’s most profitable transaction was an Informative Sell of INCY stock on January 8, 2010. The return on the trade was -49.40%.
            What is Steven M. Friedman's role in Incyte?
            Steven M. Friedman's role in Incyte is EVP, Biology & Preclinical Dev.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.